Open AccessP011: 91–94% SVR24 in HCV/HIV-1 co-infected patients treated with ombitasvir/paritaprevir/r and dasabuvir with ribavirin
Author(s) -
Chia Wang,
Roger Trinh,
Peter Ruane,
David Wyles,
Joseph Eron,
Laveeza Bhatti,
Yiran Hu,
Barbara McGovern,
Nancy S. Shulman,
Mark Sulkowski
Publication year - 2015
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.7448/ias.18.3.20142
Subject(s) - ombitasvir , dasabuvir , paritaprevir , virology , medicine , ribavirin , ritonavir , human immunodeficiency virus (hiv) , hepatitis c virus , virus , viral load , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom